Martin Meglasson

V-P, Discovery Research, LIGAND PHARMACEUTICALS INC.

Companies

Bellerophon Therapeutics (United States)Chief Scientific Officer Feb 13, 2015 to May 22, 2015¹
LIGAND PHARMACEUTICALS INCV-P, Discovery Research Mar 14, 2006 to May 11, 2010²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBellerophon Therapeutics (United States), Chief Scientific Officer
2
SEC EDGARLIGAND PHARMACEUTICALS INC, V-P, Discovery Research